Investigational Site Number 250003

Toulouse 31052

0 studies enrolling now · 2 studies all time

What they study most

Hematopoietic Neoplasm, Prostate Cancer

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer — Completed